Clinical outcome after complete response with immunotherapy in hepatocellular carcinoma.

被引：0
|
作者：
Chen, Pin-Jung
Kournoutas, Ioannis
Sanford, Alison
Kim, Naomy
Adetyan, Hasmik
Rezaee-Zavareh, Mohammad Saeid
Kuo, Alexander
Ayoub, Walid
Kaymen, Emily
Hendifar, Andrew Eugene
Tran, Nguyen H.
Yang, Ju Dong
机构：
[1] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA USA
[2] Mayo Clin Rochester, Dept Med, Rochester, MN USA
[3] Cedars Sinai Med Ctr, Karsh Div Gastroenterol & Hepatol, Los Angeles, CA USA
[4] Middle East Liver Dis MELD Ctr, Tehran, Iran
[5] Cedars Sinai Med Ctr, Comprehens Transplant Ctr, Los Angeles, CA USA
[6] Cedars Sinai Med Ctr, Dept Hematol Oncol, Los Angeles, CA USA
[7] Mayo Clin Rochester, Dept Oncol, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期
关键词：
261-374-9718-9794; 283-424-425; 261-7540; 613-4678-146-1333; 261-374; 18; 13; 9; 2; 14; 242; 182; 1854; 3; 1;
D O I：
10.1200/JCO.2025.43.4_suppl.573
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
573
引用
收藏
页码：573 / 573
页数：1
相关论文
共 50 条
  • [41] Effect of liver function on the outcome of cirrhotic patients with hepatocellular carcinoma.
    Daniele, B
    Elba, S
    Giorgio, A
    DelNaja, C
    DeSio, I
    Capuano, G
    Castiglione, F
    Farinati, F
    Felder, M
    Marone, G
    Giolitto, G
    Gallo, C
    GASTROENTEROLOGY, 1997, 112 (04) : A1252 - A1252
  • [42] Complete ablation of color Doppler signals to evaluate response to treatment with percutaneous ethanol injection for hepatocellular carcinoma.
    Sato, S
    Shiina, S
    Imamura, M
    Teratani, T
    Obi, S
    Hamamura, K
    Yosida, H
    Koike, Y
    Dan, Y
    Kawabe, T
    Okudaira, T
    Kato, N
    Yosida, H
    Shiratori, Y
    Omata, M
    GASTROENTEROLOGY, 1998, 114 (04) : A1334 - A1334
  • [43] Validation of clinical scoring systems ART and ABCR after transarterial chemoembolization of hepatocellular carcinoma.
    Kloeckner, Roman
    Pitton, Michael Bernhard
    Duber, Christoph
    Schmidtmann, Irene
    Galle, Peter R.
    Koch, Sandra
    Worns, Marcus-Alexander
    Weinmann, Arndt
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [44] Biliary differentiation and its clinical significance in hepatocellular carcinoma.
    Park, YN
    Yoon, DS
    Chi, HS
    Park, CI
    HEPATOLOGY, 1998, 28 (04) : 736A - 736A
  • [45] Clinical presentation and diagnostic features of patients with hepatocellular carcinoma.
    Romijn, MG
    Meijssen, MAC
    Bac, DJ
    Lameris, JS
    Tilanus, HW
    Schalm, SW
    Hop, WCJ
    Ijzermans, JNM
    GASTROENTEROLOGY, 1997, 112 (04) : A1367 - A1367
  • [46] Liver regeneration after hemihepatectomy in patients with hepatocellular carcinoma.
    Gong, Wen-Feng
    Zhong, Jian-Hong
    Ma, Liang
    Xiang, Bang-De
    Li, Le-Qun
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [47] Early α-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinoma
    Kim, Beom Kyung
    Ahn, Sang Hoon
    Seong, Jin Sil
    Park, Jun Yong
    Kim, Do Young
    Kim, Ja Kyung
    Lee, Do Youn
    Lee, Kwang Hoon
    Han, Kwang-Hyub
    LIVER INTERNATIONAL, 2011, 31 (03) : 369 - 376
  • [48] The management of hepatocellular carcinoma.
    Cerezo, FJM
    Garreta, J
    Miralbes, M
    Balanzo, J
    Enriquez, J
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1996, 88 (10) : 687 - 694
  • [49] Exceptional response to immunotherapy in a patient with hepatocellular carcinoma
    McCord, M. L.
    Garcia, A.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2024, 367 : S178 - S179
  • [50] Treatment of intrahepatic recurrence after resection of hepatocellular carcinoma.
    Idrissi, MSS
    Vons, C
    Borgonovo, G
    Mariette, D
    Smadja, C
    Franco, D
    ANNALES DE CHIRURGIE, 1998, 52 (06): : 543 - 546
12345